BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26521113)

  • 1. Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group.
    Stanford RH; Nagar S; Lin X; O'Connor RD
    J Manag Care Spec Pharm; 2015 Nov; 21(11):1014-9. PubMed ID: 26521113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
    Duh MS; Roberts MH; Rothnie KJ; Cheng WY; Thompson-Leduc P; Zhang S; Czira A; Slade D; Greatsinger A; Zhang A; Mapel D
    Respir Med; 2024 May; 226():107629. PubMed ID: 38593885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population.
    Wells KE; Peterson EL; Ahmedani BK; Severson RK; Gleason-Comstock J; Williams LK
    J Allergy Clin Immunol; 2012 May; 129(5):1274-1279.e2. PubMed ID: 22281166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.
    Villa-Roel C; Borgundvaag B; Majumdar SR; Emond M; Campbell S; Sivilotti M; Abu-Laban RB; Stiell IG; Aaron SD; Senthilselvan A; Rowe BH;
    J Asthma; 2019 Sep; 56(9):985-994. PubMed ID: 30311821
    [No Abstract]   [Full Text] [Related]  

  • 14. Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: A population-based observational study.
    Bloom CI; de Preux L; Sheikh A; Quint JK
    PLoS Med; 2020 Jul; 17(7):e1003145. PubMed ID: 32692744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT;
    J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma.
    Castro-Rodriguez JA; Rodrigo GJ
    Pediatrics; 2012 Sep; 130(3):e650-7. PubMed ID: 22926172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality.
    Johannes CB; McQuay LJ; Midkiff KD; Calingaert B; Andrews EB; Tennis P; Brown JS; Camargo CA; DiSantostefano RL; Rothman KJ; Stürmer T; Lanes S; Davis KJ
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):446-458. PubMed ID: 28000298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
    Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
    Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.
    Dal Negro RW; Borderias L; Zhang Q; Fan T; Sazonov V; Guilera M; Taylor SD
    BMC Pulm Med; 2009 Mar; 9():10. PubMed ID: 19331689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma.
    Lin J; Fu X; Jiang P; Song W; Hu X; Jie Z; Liu C; He Z; Zhou X; Tang H
    BMC Pulm Med; 2020 Apr; 20(1):87. PubMed ID: 32272921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.